The RLR pathway gives us another immune clue in the search for regenerative growth
William Aryitey |
From starfish and salamanders to fictional clawed superheroes, regeneration is a trait that has fascinated many – not only because it’s cool, but also because of its potential to revolutionize therapeutics. A team of researchers from Stanford University, Houston Methodist Research Institute, and Emory University School of Medicine, brought biomedicine slightly closer to realizing the dream, when they discovered another immune signaling pathway that could be manipulated to reprogram cells into pluripotency (1).
Read the full article now
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!